Diabetic Eye & Macular Disease Specialists LLC

Diabetic Eye & Macular Disease Specialists LLC was paid $374K by Medicaid between Jan 2018 and Oct 2024, across 12 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 35% of everything it billed.

33Billing provider infoDIABETIC EYE & MACULAR DISEASE SPECIALISTS LLC
WASHINGTON, DC 20017

33aNPI1225428865assigned 02/04/2015

33bProvider typeOphthalmology Physician

28Total paid$374K

24GClaims9,240

24DCodes billed12

24AFirst – last monthJan 2018 – Oct 2024

Compared with peers

Next to other Ophthalmology Physician providers in District of Columbia

Rank by total paid#7 of 29

Median peer was paid$71K

This provider vs. median5.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	1,823	$70K
2019	1,604	$68K
2020	709	$23K
2021	1,468	$58K
2022	1,605	$67K
2023	1,243	$50K
2024incomplete	788	$38K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	35%	2,134	1,908	$132K
92250		18%	2,536	2,291	$67K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	17%	547	520	$64K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	11%	959	862	$43K
92134		7.7%	1,699	1,467	$29K
67028	Intravitreal injection of a pharmacologic agent	2.9%	249	199	$11K
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	2.7%	328	283	$10K
92133		1.9%	357	322	$7K
J9035	Injection, bevacizumab, 10 mg	1.5%	159	134	$6K
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	28	27	$3K
92015	Determination of refractive state	<1%	218	196	$2K
76514		<1%	26	24	$179.11

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMATHURA, JEEVAN (SOLE OWNER)